Innovative Healing Systems   Report issue

Academic/Hospital
Founded: Tampa FL United States (2003)

Organization Overview

First Clinical Trial
2015
NCT02482948
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

collagenase clostridium histolyticum (xiaflex) (1 trial)

leptospermum honey (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2